Genmab logo

Genmab

Differentiated human antibody therapeutics for the treatment of cancer

2981 employees · est. 1999 · Denmark

VS
Visterra Inc. logo

Visterra Inc.

We bring better biologics to life. Biospace Best Place to Work 2024!

139 employees · est. 2008 · Waltham, United States

Genmab is the older company (1999 vs 2008); Genmab is the larger of the two.

Side-by-Side Comparison

Genmab Visterra Inc.
Founded
1999 older 2008
Headquarters
Denmark Waltham, United States
Employees
2981 larger 139
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
IPO Series C
Total Funding
$2.28B $125.39M
Funding Rounds
6 9
Services
Development of Antibody Therapeutics, Pipeline of Medicines, Biotech Research Not tracked yet
Target Customers
Healthcare Professionals, Patients & Care Partners, Investors, Corporate Partners Not tracked yet
Taxonomy
Antibody Therapeutics, Cancer Treatment, Bispecific Antibodies, Antibody-Drug Conjugates, Immune-Modulating Antibodies, Clinical Pipeline, Innovative Medicines, Antibody Innovation, Late-stage Clinical Trials, Biopharmaceuticals, Healthcare Innovation, Unmet Medical Needs, Drug Development Biologics, Biotechnology Company, Antibody-based Therapies, Precision Medicine, Kidney Diseases, Clinical Stage, Novel Therapies, Unmet Medical Needs, Phase 2 Clinical Development, Partnerships, Engineering Precision Antibodies, Disease Targets, Innovative Treatments, Drug Development, Biomedical Research
Website
genmab.com visterrainc.com
Genmab logo

About Genmab

Genmab, founded in 1999, is a pioneering international biotechnology company headquartered in Denmark. Renowned for its expertise in antibody innovation, Genmab focuses on developing differentiated human antibody therapeutics aimed at treating cancer and other serious diseases. Through its innovativ...

Visterra Inc. logo

About Visterra Inc.

Visterra Inc. is a United States-based biotechnology startup founded in 2007. The company's slogan, "We bring better biologics to life. Biospace Best Place to Work 2024!", reflects its commitment to innovation in antibody-based therapies. Visterra's proprietary technology platform allows for the des...

We will tell you when either one moves

BounceWatch watches Genmab and Visterra Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Genmab and Visterra Inc. — by email.

Frequently Asked Questions

Genmab — Differentiated human antibody therapeutics for the treatment of cancer. Visterra Inc. — We bring better biologics to life. Biospace Best Place to Work 2024!. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Genmab has raised $2.28B while Visterra Inc. has raised $125.39M.
Genmab and Visterra Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Genmab with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genmab on 25 Jun 2026, and Visterra Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy